Zurcher Kantonalbank Zurich Cantonalbank Makes New Investment in Genpact Limited (NYSE:G)

Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in Genpact Limited (NYSE:G - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 42,993 shares of the business services provider's stock, valued at approximately $1,847,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. SRH Advisors LLC acquired a new position in shares of Genpact during the 4th quarter worth approximately $26,000. Manchester Capital Management LLC acquired a new position in shares of Genpact during the 4th quarter worth approximately $38,000. Smartleaf Asset Management LLC grew its position in shares of Genpact by 416.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock worth $41,000 after purchasing an additional 783 shares in the last quarter. UMB Bank n.a. grew its position in shares of Genpact by 55.7% during the 4th quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock worth $52,000 after purchasing an additional 433 shares in the last quarter. Finally, J.Safra Asset Management Corp lifted its holdings in shares of Genpact by 38.8% during the 4th quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider's stock worth $69,000 after acquiring an additional 453 shares during the period. Institutional investors and hedge funds own 96.03% of the company's stock.

Genpact Trading Up 0.9 %

Shares of G stock traded up $0.46 during trading hours on Friday, hitting $49.90. 3,080,242 shares of the company's stock traded hands, compared to its average volume of 1,304,350. The stock's 50 day simple moving average is $50.13 and its 200 day simple moving average is $44.54. The stock has a market cap of $8.77 billion, a PE ratio of 17.57, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. Genpact Limited has a 12 month low of $30.23 and a 12 month high of $56.76. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50.

Remove Ads

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, sell-side analysts anticipate that Genpact Limited will post 3.21 EPS for the current year.

Genpact Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th will be paid a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, March 11th. This represents a $0.68 annualized dividend and a dividend yield of 1.36%. This is an increase from Genpact's previous quarterly dividend of $0.15. Genpact's dividend payout ratio (DPR) is presently 23.94%.

Wall Street Analyst Weigh In

G has been the subject of a number of recent analyst reports. Needham & Company LLC upped their price target on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a report on Friday, February 7th. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and upped their price target for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and upped their price target for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Finally, Mizuho upped their price target on shares of Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Six analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $48.44.

Insider Transactions at Genpact

In other Genpact news, SVP Piyush Mehta sold 12,000 shares of the firm's stock in a transaction on Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the sale, the senior vice president now directly owns 151,182 shares in the company, valued at approximately $6,475,125.06. This trade represents a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the sale, the chief executive officer now owns 310,246 shares of the company's stock, valued at $15,167,926.94. The trade was a 4.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.80% of the stock is currently owned by corporate insiders.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.